Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIPROSTENE versus hyaluronic acid injection for rhizarthrosis
2017-002298-20Phase 4Completed
- Sponsor
- CHD Vendée
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of betamethasone dipropionate + betamethasone sodium phosphate in Rhizarthrosis (3 arms), sponsored by CHD Vendée. Started Dec 2017; status: completed.
02
Drugs
betamethasone dipropionate + betamethasone sodium phosphate
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on 2017-002298-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002298-20.